Corecam Pte Ltd’s iShares Biotechnology ETF IBB Stock Holding History

Corecam Pte Ltd’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,640	Closed	-$1.25M	–	65
2025 Q3	$1.25M	Buy	+8,640	New	+$1.18M	0.65%	23

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Corecam Pte Ltd's IBB Position: Q4 2025 in Review

Corecam Pte Ltd sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 8,640 shares — an estimated $1.25M sold.

Corecam Pte Ltd first reported a position in IBB in Q3 2025 and held it in 1 quarter. The position peaked at $1.25M in Q3 2025. 956 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

Corecam Pte Ltd reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
Corecam Pte Ltd sold 8,640 iShares Biotechnology ETF shares in Q4 2025, an estimated $1.25M.
Corecam Pte Ltd first reported a position in iShares Biotechnology ETF in Q3 2025 and held it in 1 quarter.
Corecam Pte Ltd's iShares Biotechnology ETF position peaked at $1.25M in Q3 2025.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Corecam Pte Ltd's 13F filing for Q4 2025, filed 2 Mar 2026.